Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder characterized by pulmonary venous constriction or occlusion, resulting in pulmonary hypertension.
Biomarker and diagnostic research for pulmonary venoocclusive disease has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for pulmonary venoocclusive disease.
122 publications have been identified in PubMed for pulmonary venoocclusive disease. Research spans Case Report / Case Series (27%), Clinical Trial Publication (19%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 33 | 27% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:46 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Clinical study results
23 |
19% |
Laboratory research | 21 | 17% |
Disease patterns and progression | 17 | 14% |
Research summaries | 13 | 11% |
Testing and diagnosis research | 10 | 8% |
New treatment approaches | 4 | 3% |
Other research | 1 | 1% |
Berkane AW (2026). [PMID: 42001268](https://pubmed.ncbi.nlm.nih.gov/42001268/). *Ann Saudi Med*. [Epidemiology / Natural History]
Prabhakar A (2026). [PMID: 41264364](https://pubmed.ncbi.nlm.nih.gov/41264364/). *The Journal of clinical investigation*. [Case Report / Case Series]
Shaukat M (2026). [PMID: 41611798](https://pubmed.ncbi.nlm.nih.gov/41611798/). *Scientific reports*. [Basic Science / Preclinical]
Kolaitis NA (2026). [PMID: 40581270](https://pubmed.ncbi.nlm.nih.gov/40581270/). *The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation*. [Epidemiology / Natural History]
Grynblat J (2026). [PMID: 42114419](https://pubmed.ncbi.nlm.nih.gov/42114419/). *Respir Med Res*. [Basic Science / Preclinical]
Fujisaki S (2026). [PMID: 41727705](https://pubmed.ncbi.nlm.nih.gov/41727705/). *Pulmonary circulation*. [Basic Science / Preclinical]
Rachid C (2026). [PMID: 41646601](https://pubmed.ncbi.nlm.nih.gov/41646601/). *Cureus*. [Case Report / Case Series]
Radchenko G (2026). [PMID: 41588905](https://pubmed.ncbi.nlm.nih.gov/41588905/). *Current cardiology reviews*. [Case Report / Case Series]
Polini B (2026). [PMID: 41526595](https://pubmed.ncbi.nlm.nih.gov/41526595/). *GeroScience*. [Diagnostic / Biomarker]
Manso Tejerina P (2026). [PMID: 41772943](https://pubmed.ncbi.nlm.nih.gov/41772943/). *Clinical transplantation*. [Basic Science / Preclinical]
AI-curated news mentioning pulmonary venoocclusive disease
Updated Aug 20, 2026
A recent study highlights pulmonary veno-occlusive disease as a potential presentation of congenital heart disease-associated pulmonary hypertension. This discovery may influence diagnostic approaches and treatment strategies for affected patients.
A recent study published in PubMed examines the impact of pulmonary veno-occlusive disease on posttransplant survival rates in patients with pulmonary hypertension. The findings highlight the need for tailored posttransplant management strategies for this patient population.